Literature DB >> 5041507

The physiological disposition of 14 C-methsuximide in the rat.

P J Nicholls, T C Orton.   

Abstract

1. (14)C-Methsuximide (N-methyl-(14)C-2-methyl-2-phenylsuccinimide) was rapidly absorbed from the small intestine of the rat (t(1/2) 17.4 min).2. The drug was rapidly and fairly evenly distributed throughout the body with peak blood and tissue levels occurring 1 h after oral administration. At all times, adrenals, body fat, kidneys and liver had higher levels of (14)C-methsuximide than other tissues and the drug freely traversed the blood-brain barrier. However, radioactivity disappeared rapidly from most tissues after the initial phase of the distribution.3. During 24 h, 26% of the orally administered radioactivity was recovered in urine and 29% appeared in expired air as (14)CO(2). The excretion of (14)CO(2) indicated N-demethylation of (14)C-methsuximide to 2-methyl-2-phenylsuccinimide. 2.7% of an administered dose of methsuximide was excreted unchanged in 24 h urine and 2.7% appeared as 2-methyl-2-phenylsuccinimide. 2-Methyl-2-phenylsuccinimide was also detected as a urinary metabolite of methsuximide in man.4. 2-Methyl-2-phenylsuccinimide possesses anticonvulsant activity and it is suggested that this metabolite contributes to the overall anticonvulsant activity and toxicity of methsuximide.5. Rat urine also contained a radioactive substance with similar chromatographic properties to one of the products of alkaline hydrolysis of methsuximide. This compound may arise from the spontaneous decomposition of the parent drug in vivo.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5041507      PMCID: PMC1666192          DOI: 10.1111/j.1476-5381.1972.tb09575.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Use of celontin in the treatment of mixed epilepsy.

Authors:  C H CARTER; M C MALEY
Journal:  Neurology       Date:  1957-07       Impact factor: 9.910

2.  Renal excretion of 5,5-dimethyl-2-4-oxazolidinedione (product of demethylation of trimethadione.

Authors:  W J WADDELL; T C BUTLER
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

3.  New drugs in the treatment of petit mal epilepsy.

Authors:  F T ZIMMERMAN
Journal:  Am J Psychiatry       Date:  1953-04       Impact factor: 18.112

4.  The anticonvulsant activity of o-phenyl succinimides.

Authors:  G CHEN; R PORTMAN; C R ENSOR; A C BRATTON
Journal:  J Pharmacol Exp Ther       Date:  1951-09       Impact factor: 4.030

5.  Absorption, distribution and excretion of methsuximide in male rats.

Authors:  P J Nicholls; T C Orton
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

6.  Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates.

Authors:  J T Doluisio; N F Billups; L W Dittert; E T Sugita; J V Swintosky
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

7.  Demethylation of trimethadione and metharbital by rat liver microsomal enzymes: substrate concentration--yield relationships and competition between substrates.

Authors:  T C Butler; W J Waddell; D T Poole
Journal:  Biochem Pharmacol       Date:  1965-06       Impact factor: 5.858

8.  The estimation of some important anticonvulsant drugs in serum.

Authors:  J W Huisman
Journal:  Clin Chim Acta       Date:  1966-03       Impact factor: 3.786

9.  Studies on food additives. X. The metabolism of p-ethoxyphenylurea in the rabbit.

Authors:  M Akagi; I Aoki; T Uematsu
Journal:  Chem Pharm Bull (Tokyo)       Date:  1966-01       Impact factor: 1.645

10.  Quantitative studies of the demethylation of trimethadione (tridione).

Authors:  T C BUTLER
Journal:  J Pharmacol Exp Ther       Date:  1953-05       Impact factor: 4.030

View more
  2 in total

Review 1.  Effect of active drug metabolites on plasma level-response correlations.

Authors:  A J Atkinson; J M Strong
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

2.  Studies on the absorption, distribution and elimination of 6-o-chlorophenyl-2,4-dihydro-2(N-methyl-piperazin-1-yl)-methylene-8-nitro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-one methanesulphonate in the male rat and rabbit.

Authors:  G W James; P D Kennewell; J B Taylor; D K Luscombe; P J Nicholls
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.